BlackRock Health Sciences Trust II Cash Flow Conversion Efficiency
BlackRock Health Sciences Trust II cash flow conversion efficiency. Based on the latest financial reports, BlackRock Health Sciences Trust II (BMEZ) has a cash flow conversion efficiency ratio of 0.103x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($78.91 Million) by net assets ($768.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of BlackRock Health Sciences Trust II (2019–2024)
Cash flow conversion efficiency of BlackRock Health Sciences Trust II from 2019 to 2024. This chart illustrates how BlackRock Health Sciences Trust II's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest BlackRock Health Sciences Trust II stock price today for real-time trading data and today's change.
BlackRock Health Sciences Trust II Cash Flow Conversion Ratio Explained
BlackRock Health Sciences Trust II cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
BlackRock Health Sciences Trust II Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BlackRock Health Sciences Trust II ranked by their cash flow conversion efficiency. Also see market value of BlackRock Health Sciences Trust II for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hanza AB
ST:HANZA
|
0.066x |
|
Invisio Communications AB
ST:IVSO
|
0.047x |
|
Nanfang Pump Industry
SHE:300145
|
0.063x |
|
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513
|
0.020x |
|
Wolfspeed, Inc.
NYSE:WOLF
|
-0.058x |
|
Anhui Hwasu Co.Ltd.
SHG:600935
|
N/A |
|
Inner Mongolia ERDOS Resources Co Ltd B
SHG:900936
|
0.075x |
|
Excelerate Energy Inc
NYSE:EE
|
0.077x |
Annual Cash Flow Conversion Efficiency for BlackRock Health Sciences Trust II (2019–2024)
The table below shows the annual cash flow conversion efficiency of BlackRock Health Sciences Trust II from 2019 to 2024. Review BMEZ free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $768.57 Million | $65.52 Million | 0.085x | +56.59% |
| 2023-12-31 | $588.14 Million | $32.02 Million | 0.054x | +3838.40% |
| 2022-12-31 | $600.20 Million | $-874.04K | -0.001x | +95.77% |
| 2021-12-31 | $625.77 Million | $-21.56 Million | -0.034x | -117.55% |
| 2020-12-31 | $545.94 Million | $107.17 Million | 0.196x | +121.20% |
| 2019-12-31 | $1.64 Billion | $-1.52 Billion | -0.926x | -- |
About BlackRock Health Sciences Trust II
BlackRock Health Sciences Trust II operates in various business sectors.